Page last updated: 2024-10-25

cyclandelate and Diabetic Retinopathy

cyclandelate has been researched along with Diabetic Retinopathy in 2 studies

Cyclandelate: A direct-acting SMOOTH MUSCLE relaxant used to dilate BLOOD VESSELS.
cyclandelate : The ester obtained by formal condensation of mandelic acid and 3,3,5-tricyclohexanol. It is a direct-acting smooth muscle relaxant used to dilate blood vessels.

Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cunha-Vaz, JG2
Reis Fonseca, J1
Hagenouw, JR1
Mota, MC1
Leite, E1
Ruas, MA1
Verjans, HL1
Blakemore, CB1

Trials

2 trials available for cyclandelate and Diabetic Retinopathy

ArticleYear
Treatment of early diabetic retinopathy with cyclandelate.
    The British journal of ophthalmology, 1977, Volume: 61, Issue:6

    Topics: Adult; Aged; Capillary Permeability; Clinical Trials as Topic; Cyclandelate; Diabetic Retinopathy; D

1977
Effect of cyclospasmol on early diabetic retinopathy.
    International ophthalmology, 1987, Volume: 10, Issue:1

    Topics: Adolescent; Adult; Blood-Retinal Barrier; Clinical Trials as Topic; Cyclandelate; Diabetic Retinopat

1987